{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:07:27Z","timestamp":1789495647785,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007899","name":"University of Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007899","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.maturitas.2018.03.012","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T23:16:25Z","timestamp":1522970185000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Microbiota\u2013drug interactions: Impact on metabolism and efficacy of therapeutics"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6756-8117","authenticated-orcid":false,"given":"Ellen M.","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra Esra","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Herbst-Kralovetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.maturitas.2018.03.012_bib0005","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri1373","article-title":"Interactions between commensal intestinal bacteria and the immune system","volume":"4","author":"Macpherson","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00281-013-0399-z","article-title":"Gut microbiome and metabolic diseases","volume":"36","author":"Fukuda","year":"2014","journal-title":"Semin. Immunopathol."},{"issue":"8","key":"10.1016\/j.maturitas.2018.03.012_bib0015","doi-asserted-by":"crossref","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol."},{"issue":"17","key":"10.1016\/j.maturitas.2018.03.012_bib0020","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.3748\/wjg.v21.i17.5359","article-title":"Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review","volume":"21","author":"Rossen","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ebiom.2016.09.029","article-title":"Fecal microbiota-based therapeutics for recurrent clostridium difficile infection, ulcerative colitis and obesity","volume":"13","author":"Carlucci","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.maturitas.2018.03.012_bib0030","first-page":"26878","article-title":"Approaches to studying and manipulating the enteric microbiome to improve autism symptoms","volume":"26","author":"Frye","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"issue":"5","key":"10.1016\/j.maturitas.2018.03.012_bib0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.chom.2012.10.012","article-title":"Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications","volume":"12","author":"Backhed","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.maturitas.2018.03.012_bib0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-micro-092611-150157","article-title":"Vaginal microbiome: rethinking health and disease","volume":"66","author":"Ma","year":"2012","journal-title":"Annu. Rev. Microbiol."},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2018.03.012_bib0050","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5944","key":"10.1016\/j.maturitas.2018.03.012_bib0055","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.1176950","article-title":"Functional characterization of the antibiotic resistance reservoir in the human microflora","volume":"325","author":"Sommer","year":"2009","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.maturitas.2018.03.012_bib0060","doi-asserted-by":"crossref","first-page":"e1004903","DOI":"10.1371\/journal.ppat.1004903","article-title":"Risks of antibiotic exposures early in life on the developing microbiome","volume":"11","author":"Schulfer","year":"2015","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.maturitas.2018.03.012_bib0065","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","article-title":"Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences","volume":"158","author":"Cox","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.maturitas.2018.03.012_bib0070","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1373\/clinchem.2012.187617","article-title":"The human gut microbiome and body metabolism: implications for obesity and diabetes","volume":"59","author":"Devaraj","year":"2013","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.maturitas.2018.03.012_bib0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrg.2016.12","article-title":"The genetics of drug efficacy: opportunities and challenges","volume":"17","author":"Nelson","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"8","key":"10.1016\/j.maturitas.2018.03.012_bib0080","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/jix420","article-title":"The female genital tract microbiome is associated with vaginal antiretroviral drug concentrations in human immunodeficiency virus-infected women on antiretroviral therapy","volume":"216","author":"Donahue Carlson","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.maturitas.2018.03.012_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.07.009","article-title":"The gastrointestinal microbiota as a site for the biotransformation of drugs","volume":"363","author":"Sousa","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.maturitas.2018.03.012_bib0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cmet.2014.07.002","article-title":"Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology","volume":"20","author":"Patterson","year":"2014","journal-title":"Cell Metab."},{"issue":"6341","key":"10.1016\/j.maturitas.2018.03.012_bib0095","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.aai9383","article-title":"Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women","volume":"356","author":"Klatt","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2012.07.009","article-title":"Developing a metagenomic view of xenobiotic metabolism","volume":"69","author":"Haiser","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"6356","key":"10.1016\/j.maturitas.2018.03.012_bib0105","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.maturitas.2018.03.012_bib0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrmicro.2016.17","article-title":"The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism","volume":"14","author":"Spanogiannopoulos","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","article-title":"Gut microbiome interactions with drug metabolism, efficacy, and toxicity","volume":"179","author":"Wilson","year":"2017","journal-title":"Transl. Res."},{"issue":"9","key":"10.1016\/j.maturitas.2018.03.012_bib0120","doi-asserted-by":"crossref","first-page":"e6958","DOI":"10.1371\/journal.pone.0006958","article-title":"Intestinal microbiota regulate xenobiotic metabolism in the liver","volume":"4","author":"Bjorkholm","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.maturitas.2018.03.012_bib0125","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/infdis\/jiu004","article-title":"Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner","volume":"209","author":"Doerflinger","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.maturitas.2018.03.012_bib0130","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/infdis\/jis465","article-title":"Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel","volume":"206","author":"Naranbhai","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1871520615666150824153523","article-title":"The immune system in cancer prevention, development and therapy","volume":"16","author":"Candeias","year":"2016","journal-title":"Anticancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.maturitas.2018.03.012_bib0140","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","article-title":"The impact of the gut microbiota on human health: an integrative view","volume":"148","author":"Clemente","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.maturitas.2018.03.012_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1749-8090-6-137","article-title":"Bacterial and fungal microflora in surgically removed lung cancer samples","volume":"6","author":"Apostolou","year":"2011","journal-title":"J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.maturitas.2018.03.012_bib0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/1040841X.2013.776511","article-title":"Tumor-colonizing bacteria: a potential tumor targeting therapy","volume":"40","author":"Zu","year":"2014","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","article-title":"Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer","volume":"741","author":"de Sousa Cavalcante","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0160","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.drudis.2017.10.010","article-title":"Gemcitabine and glioblastoma: challenges and current perspectives","volume":"23","author":"Bastiancich","year":"2017","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0165","doi-asserted-by":"crossref","first-page":"14554","DOI":"10.1038\/srep14554","article-title":"Local bacteria affect the efficacy of chemotherapeutic drugs","volume":"5","author":"Lehouritis","year":"2015","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.maturitas.2018.03.012_bib0170","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4161\/cbt.7.12.6940","article-title":"Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats","volume":"7","author":"Stringer","year":"2008","journal-title":"Cancer Biol. Ther."},{"issue":"16","key":"10.1016\/j.maturitas.2018.03.012_bib0175","first-page":"3752","article-title":"Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats","volume":"56","author":"Takasuna","year":"1996","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.maturitas.2018.03.012_bib0180","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/bjc.1993.427","article-title":"Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer","volume":"68","author":"Masuda","year":"1993","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.1992.10.1.16","article-title":"A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer","volume":"10","author":"Fukuoka","year":"1992","journal-title":"J. Clin. Oncol."},{"issue":"6005","key":"10.1016\/j.maturitas.2018.03.012_bib0190","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1126\/science.1191175","article-title":"Alleviating cancer drug toxicity by inhibiting a bacterial enzyme","volume":"330","author":"Wallace","year":"2010","journal-title":"Science"},{"issue":"6161","key":"10.1016\/j.maturitas.2018.03.012_bib0195","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.maturitas.2018.03.012_bib0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.micres.2014.11.002","article-title":"Effects of cyclophosphamide on immune system and gut microbiota in mice","volume":"171","author":"Xu","year":"2015","journal-title":"Microbiol. Res."},{"issue":"47","key":"10.1016\/j.maturitas.2018.03.012_bib0205","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.maturitas.2018.03.012_bib0210","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.maturitas.2018.03.012_bib0215","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"issue":"6161","key":"10.1016\/j.maturitas.2018.03.012_bib0220","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.maturitas.2018.03.012_bib0225","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.2741\/934","article-title":"CpG-oligonucleotides for cancer immunotherapy: review of the literature and potential applications in malignant glioma","volume":"8","author":"Carpentier","year":"2003","journal-title":"Front. Biosci."},{"issue":"8","key":"10.1016\/j.maturitas.2018.03.012_bib0230","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1158\/0008-5472.CAN-04-4262","article-title":"Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection","volume":"65","author":"Guiducci","year":"2005","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.maturitas.2018.03.012_bib0235","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/intimm\/dxw015","article-title":"Vaccine adjuvants as potential cancer immunotherapeutics","volume":"28","author":"Temizoz","year":"2016","journal-title":"Int. Immunol."},{"issue":"8","key":"10.1016\/j.maturitas.2018.03.012_bib0240","first-page":"3105","article-title":"CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma","volume":"9","author":"Weigel","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.uct.2007.11.003","article-title":"CpG oligodeoxynucleotides as immunotherapy in cancer","volume":"3","author":"Jahrsdorfer","year":"2008","journal-title":"Update Cancer Ther."},{"issue":"2","key":"10.1016\/j.maturitas.2018.03.012_bib0250","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coi.2006.01.011","article-title":"Principles and use of anti-CTLA4 antibody in human cancer immunotherapy","volume":"18","author":"Peggs","year":"2006","journal-title":"Curr. Opin. Immunol."},{"issue":"6264","key":"10.1016\/j.maturitas.2018.03.012_bib0255","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.maturitas.2018.03.012_bib0260","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1200\/JCO.2005.04.5716","article-title":"Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4","volume":"24","author":"Beck","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD \u22121 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.maturitas.2018.03.012_bib0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3121\/cmr.2007.698","article-title":"An evidence-based update on nonsteroidal anti-inflammatory drugs","volume":"5","author":"Ong","year":"2007","journal-title":"Clin. Med. Res."},{"issue":"4","key":"10.1016\/j.maturitas.2018.03.012_bib0280","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5217\/ir.2017.15.4.446","article-title":"Non-steroidal anti-inflammatory drug-induced enteropathy","volume":"15","author":"Shin","year":"2017","journal-title":"Intest. Res."},{"issue":"6","key":"10.1016\/j.maturitas.2018.03.012_bib0285","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","article-title":"Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans","volume":"104","author":"Bjarnason","year":"1993","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.maturitas.2018.03.012_bib0290","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","article-title":"Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?","volume":"88","author":"Wallace","year":"2008","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.maturitas.2018.03.012_bib0295","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-2952(88)90729-0","article-title":"2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism","volume":"37","author":"Grootveld","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0300","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bcp.2016.09.023","article-title":"Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin","volume":"122","author":"Kim","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.maturitas.2018.03.012_bib0305","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/00365521.2015.1018937","article-title":"5-Aminosalicylic acid, a specific drug for ulcerative colitis","volume":"50","author":"Hauso","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.maturitas.2018.03.012_bib0310","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1002\/jps.24103","article-title":"On the colonic bacterial metabolism of azo-bonded prodrugsof 5-aminosalicylic acid","volume":"103","author":"Sousa","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.maturitas.2018.03.012_bib0315","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3565(25)29238-2","article-title":"The role of intestinal bacteria in the metabolism of salicylazosulfapyridine","volume":"181","author":"Peppercorn","year":"1972","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.maturitas.2018.03.012_bib0320","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v23.i5.10","article-title":"Azo chemistry and its potential for colonic delivery","volume":"23","author":"Jain","year":"2006","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"6","key":"10.1016\/j.maturitas.2018.03.012_bib0325","first-page":"424","article-title":"Clinical use of systemic antifungal agents","volume":"7","author":"Benson","year":"1988","journal-title":"Clin. Pharm."},{"issue":"10","key":"10.1016\/j.maturitas.2018.03.012_bib0330","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1128\/AAC.49.10.4220-4226.2005","article-title":"Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis","volume":"49","author":"te Dorsthorst","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.maturitas.2018.03.012_bib0335","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"issue":"1\u20132","key":"10.1016\/j.maturitas.2018.03.012_bib0340","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000069784","article-title":"An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora","volume":"49","author":"Vermes","year":"2003","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0345","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3904\/kjim.2006.21.1.43","article-title":"Unpredicted severe toxicity after 5-fluorouracil treatment due to dihydropyrimidine dehydrogenase deficiency","volume":"21","author":"Baek","year":"2006","journal-title":"Korean J. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2018.03.012_bib0350","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/647939","article-title":"Metronidazole is still the drug of choice for treatment of anaerobic infections","volume":"50","author":"Lofmark","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.maturitas.2018.03.012_bib0355","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00003495-199754050-00003","article-title":"Metronidazole A therapeutic review and update","volume":"54","author":"Freeman","year":"1997","journal-title":"Drugs"},{"issue":"24","key":"10.1016\/j.maturitas.2018.03.012_bib0360","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/0006-2952(79)90407-6","article-title":"Acetamide\u2013a metabolite of metronidazole formed by the intestinal flora","volume":"28","author":"Koch","year":"1979","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.maturitas.2018.03.012_bib0365","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1086\/516306","article-title":"Late incidence of cancer after metronidazole use: a matched metronidazole user\/nonuser study","volume":"26","author":"Falagas","year":"1998","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0370","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0041-008X(69)90176-8","article-title":"Prevention by arginine glutamate of the carcinogenicity of acetamide in rats","volume":"14","author":"Weisburger","year":"1969","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0375","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-9610(83)90168-X","article-title":"Increased incidence of experimental colon cancer associated with long-term metronidazole therapy","volume":"145","author":"Sloan","year":"1983","journal-title":"Am. J. Surg."},{"issue":"11","key":"10.1016\/j.maturitas.2018.03.012_bib0380","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1002\/jps.21720","article-title":"Synthesis and evaluation of N-nicotinoyl-2-{2-(2-methyl-5-nitroimidazol-1-yl)ethyloxy}-D, L-glycine as a colon-specific prodrug of metronidazole","volume":"98","author":"Kim","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0385","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","article-title":"Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin","volume":"47","author":"Petrina","year":"2017","journal-title":"Anaerobe"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2018.03.012_bib0390","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1093\/infdis\/jiw130","article-title":"New systems for studying intercellular interactions in bacterial vaginosis","volume":"214","author":"Herbst-Kralovetz","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.maturitas.2018.03.012_bib0395","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrmicro.2015.25","article-title":"The influence of commensal bacteria on infection with enteric viruses","volume":"14","author":"Karst","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.maturitas.2018.03.012_bib0400","doi-asserted-by":"crossref","DOI":"10.3390\/v9030058","article-title":"Virus-bacteria interactions an emerging topic in human infection","volume":"9","author":"Almand","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.maturitas.2018.03.012_bib0405","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev-virology-031413-085550","article-title":"Viruses and the microbiota","volume":"1","author":"Robinson","year":"2014","journal-title":"Annu. Rev. Virol."},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00008571-199702000-00005","article-title":"Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil","volume":"7","author":"Nakayama","year":"1997","journal-title":"Pharmacogenetics"},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2125.1998.00050.x","article-title":"Sorivudine and 5-fluorouracil; a clinically significant drug\u2013drug interaction due to inhibition of dihydropyrimidine dehydrogenase","volume":"46","author":"Diasio","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.maturitas.2018.03.012_bib0420","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0026-895X(24)26498-1","article-title":"Mechanism-based inactivation of human dihydropyrimidine dehydrogenase by (E)-5-(2-bromovinyl)uracil in the presence of NADPH","volume":"57","author":"Nishiyama","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"6510","key":"10.1016\/j.maturitas.2018.03.012_bib0425","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection","volume":"373","author":"Wei","year":"1995","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.maturitas.2018.03.012_bib0430","first-page":"2789","article-title":"Combination antiretroviral therapy for HIV infection","volume":"57","author":"Maenza","year":"1998","journal-title":"Am. Fam. Phys."},{"issue":"12","key":"10.1016\/j.maturitas.2018.03.012_bib0435","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1128\/AAC.00363-08","article-title":"Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers","volume":"52","author":"Huang","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.16.1.18567","article-title":"Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability","volume":"16","author":"Usach","year":"2013","journal-title":"J. Int. AIDS Soc."},{"issue":"6","key":"10.1016\/j.maturitas.2018.03.012_bib0445","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1124\/dmd.111.044362","article-title":"Metabolic switching of BILR 355 in the presence of ritonavir. II. Uncovering novel contributions by gut bacteria and aldehyde oxidase","volume":"40","author":"Li","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.maturitas.2018.03.012_bib0450","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1016\/S2352-3018(17)30110-8","article-title":"Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study","volume":"4","author":"Heffron","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.maturitas.2018.03.012_bib0455","first-page":"62","article-title":"Culturing and applications of rotating wall vessel bioreactor derived 3D epithelial cell models","author":"Radtke","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.maturitas.2018.03.012_bib0460","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1095\/biolreprod.109.080408","article-title":"Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model","volume":"82","author":"Hjelm","year":"2010","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0465","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-genom-090711-163814","article-title":"The human microbiome: our second genome","volume":"13","author":"Grice","year":"2012","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"12","key":"10.1016\/j.maturitas.2018.03.012_bib0470","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.mayocp.2017.10.004","article-title":"Microbiome at the frontier of personalized medicine","volume":"92","author":"Kashyap","year":"2017","journal-title":"Mayo Clin. Proc."},{"issue":"10","key":"10.1016\/j.maturitas.2018.03.012_bib0475","first-page":"560","article-title":"Personalized medicine: part 1: evolution and development into theranostics","volume":"35","author":"Vogenberg","year":"2010","journal-title":"P T"},{"issue":"6","key":"10.1016\/j.maturitas.2018.03.012_bib0480","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1139\/w05-031","article-title":"Effect of some pharmaceutical excipients on the survival of probiotic vaginal lactobacilli","volume":"51","author":"Zarate","year":"2005","journal-title":"Can. J. Microbiol."},{"issue":"2","key":"10.1016\/j.maturitas.2018.03.012_bib0485","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.2002.tb11467.x","article-title":"The microbiology of butyrate formation in the human colon","volume":"217","author":"Pryde","year":"2002","journal-title":"FEMS Microbiol. Lett."},{"issue":"2","key":"10.1016\/j.maturitas.2018.03.012_bib0490","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/obr.12626","article-title":"Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Borgeraas","year":"2018","journal-title":"Obes. Rev."},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0495","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.patbio.2014.10.003","article-title":"The psychomicrobiotic: targeting microbiota in major psychiatric disorders: a systematic review","volume":"63","author":"Fond","year":"2015","journal-title":"Pathol. Biol. (Paris)"},{"issue":"10","key":"10.1016\/j.maturitas.2018.03.012_bib0500","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/MIB.0000000000001228","article-title":"Systematic review and meta-analysis. fecal microbiota transplantation for treatment of active ulcerative colitis","volume":"23","author":"Narula","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"issue":"8","key":"10.1016\/j.maturitas.2018.03.012_bib0505","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpediatrics.2009.94","article-title":"Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials","volume":"163","author":"Rao","year":"2009","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.maturitas.2018.03.012_bib0510","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2016.05.015","article-title":"Menopause and the vaginal microbiome","volume":"91","author":"Muhleisen","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2018.03.012_bib0515","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen-gut microbiome axis: physiological and clinical implications","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.maturitas.2018.03.012_bib0520","doi-asserted-by":"crossref","first-page":"11102","DOI":"10.1038\/s41598-017-10734-y","article-title":"Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients","volume":"7","author":"Ticinesi","year":"2017","journal-title":"Sci. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2018.03.012_bib0525","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"12","key":"10.1016\/j.maturitas.2018.03.012_bib0530","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s40262-016-0422-3","article-title":"Development of a whole-body physiologically based pharmacokinetic approach to assess the pharmacokinetics of drugs in elderly individuals","volume":"55","author":"Schlender","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.maturitas.2018.03.012_bib0535","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00262-009-0665-z","article-title":"Immunosenescence and cancer vaccines","volume":"58","author":"Provinciali","year":"2009","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512218301348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512218301348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:11:44Z","timestamp":1759914704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512218301348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":107,"alternative-id":["S0378512218301348"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2018.03.012","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota\u2013drug interactions: Impact on metabolism and efficacy of therapeutics","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2018.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}